Hebrew Home at Riverdale Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2018
NCT03389100
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Hebrew Home at Riverdale | Research Division, Hebrew Home at Riverdale

Active Ingredients

Drugs in Phase 2 Trials (1)

18f-mk6240 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Prediabetic State (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1